Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) have been assigned an average recommendation of “Hold” from the eight brokerages that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $34.00.

A number of research analysts have recently issued reports on PAHC shares. Piper Jaffray Companies set a $42.00 target price on Phibro Animal Health Corporation and gave the company a “buy” rating in a report on Friday, August 25th. BidaskClub lowered Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Credit Suisse Group lowered Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $29.00 to $36.00 in a report on Friday, June 2nd. Finally, Bank of America Corporation reissued an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd.

In related news, VP Daniel M. Bendheim sold 5,938 shares of the company’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $40.04, for a total transaction of $237,757.52. Following the transaction, the vice president now owns 300 shares of the company’s stock, valued at $12,012. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Richard G. Johnson sold 29,807 shares of the company’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $35.66, for a total value of $1,062,917.62. Following the transaction, the chief financial officer now directly owns 4,240 shares in the company, valued at approximately $151,198.40. The disclosure for this sale can be found here. Insiders have sold 404,448 shares of company stock worth $14,756,514 in the last ninety days. 48.09% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of PAHC. Janus Henderson Group PLC acquired a new stake in Phibro Animal Health Corporation in the second quarter valued at $6,353,000. AJO LP acquired a new stake in Phibro Animal Health Corporation in the second quarter valued at $5,815,000. FMR LLC grew its holdings in Phibro Animal Health Corporation by 31.9% in the second quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after purchasing an additional 141,274 shares during the last quarter. Vanguard Group Inc. grew its holdings in Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock valued at $48,597,000 after purchasing an additional 130,935 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in Phibro Animal Health Corporation by 50.6% in the second quarter. Ameriprise Financial Inc. now owns 339,996 shares of the company’s stock valued at $12,599,000 after purchasing an additional 114,230 shares during the last quarter. 48.06% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Phibro Animal Health Corporation (PAHC) Receives Average Rating of “Hold” from Analysts” was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.americanbankingnews.com/2017/09/23/phibro-animal-health-corporation-pahc-receives-average-rating-of-hold-from-analysts.html.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.14% during trading on Friday, reaching $35.40. 65,288 shares of the company traded hands. Phibro Animal Health Corporation has a 1-year low of $24.83 and a 1-year high of $40.25. The company has a market capitalization of $1.41 billion, a price-to-earnings ratio of 21.99 and a beta of 1.36. The stock’s 50 day moving average is $37.87 and its 200 day moving average is $33.97.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its earnings results on Wednesday, August 30th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.04. The business had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.32 earnings per share. On average, analysts forecast that Phibro Animal Health Corporation will post $1.56 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio is presently 24.69%.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Analyst Recommendations for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.